AllQuantitative Report
Argus•May 12, 2021
Argus•May 12, 2021EGRX: What does Argus have to say about EGRX?
Summary
Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas o
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeActions
Download Full ReportRelated Reports
- AMPH: What does Argus have to say about AMPH?Apr 17, 2024 •
AMPH
- ANIP: Lowering target price to $69.00Apr 17, 2024 •
ANIP
- IRWD: What does Argus have to say about IRWD?Apr 17, 2024 •
IRWD
- SUPN: Lowering target price to $31.00Apr 17, 2024 •
SUPN
- COLL: Lowering target price to $37.00Apr 17, 2024 •
COLL